CYPH - Cytoclonal Pharmaceutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPH - Cytoclonal Pharmaceutics

CYPH 0.629

+1.8%

Feb 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: john lilly who wrote ()	10/30/1998 4:44:00 PM
From: blackmerlin	of 428

Sicameron, "Proof of Concept" usually involves 2 independent labs: Sicameron. Thank you for bringing up the information in your post on fungal taxol on the Yahoo CYPH board (#2680). However, "proof of concept" usually entails getting comparable results in at least two independent laboratories. The two references you gave were from the same laboratories and the same investigators. Try Again. HPARCH you mentioned something interesting in your Yahoo CYPH #2677 post. This was that you heard that the street favors NPRO. NPRO, at a price of $1-2, a $2.4 million payment already booked this quarter from IVXBioScience, and a patented delivery for taxol in clinical trials, indicates that there may be some wisdom there. HPARCH why not hedge you bet and also go long on NPRO. It can't hurt at the NPRO stock price. Believe me, I am on top of the issues. I really want to help the CYPH investors. That way if you have to wait a little longer for CYPH deals, a least you will make some money in the short-term (next 2 or 3 months) by adding NPRO. Then some day instead of calling me names, you will thank me. Regards, Blackmerlin

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next